232 related articles for article (PubMed ID: 15925076)
1. Photoselective vaporization of the prostate: the basel experience after 108 procedures.
Bachmann A; Ruszat R; Wyler S; Reich O; Seifert HH; Müller A; Sulser T
Eur Urol; 2005 Jun; 47(6):798-804. PubMed ID: 15925076
[TBL] [Abstract][Full Text] [Related]
2. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
[TBL] [Abstract][Full Text] [Related]
3. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
4. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.
Sandhu JS; Ng C; Vanderbrink BA; Egan C; Kaplan SA; Te AE
Urology; 2004 Dec; 64(6):1155-9. PubMed ID: 15596189
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of 80 W KTP laser vaporization of the large prostate.
Tugcu V; Tasci AI; Sahin S; Ordekci Y; Karakas OF; Zorluoglu F
Urol Int; 2007; 79(4):316-20. PubMed ID: 18025849
[TBL] [Abstract][Full Text] [Related]
6. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
7. Photoselective vaporization of the prostate using high power (80 W) KTP laser: one year follow up of the first 101 patients in Japan.
Hori Y; Kuromatsu I; Sugimura Y
Int J Urol; 2008 Dec; 15(12):1067-71. PubMed ID: 19054171
[TBL] [Abstract][Full Text] [Related]
8. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.
Paick JS; Um JM; Kwak C; Kim SW; Ku JH
Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922
[TBL] [Abstract][Full Text] [Related]
9. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
Kumar SM
J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
[TBL] [Abstract][Full Text] [Related]
10. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia.
Fu WJ; Hong BF; Wang XX; Yang Y; Cai W; Gao JP; Chen YF; Zhang CE
Asian J Androl; 2006 May; 8(3):367-71. PubMed ID: 16625289
[TBL] [Abstract][Full Text] [Related]
12. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients.
Reich O; Bachmann A; Siebels M; Hofstetter A; Stief CG; Sulser T
J Urol; 2005 Jan; 173(1):158-60. PubMed ID: 15592063
[TBL] [Abstract][Full Text] [Related]
13. [Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with oral anticoagulant therapy].
Hori Y; Kuromatsu I; Sugimura Y
Hinyokika Kiyo; 2008 Oct; 54(10):651-6. PubMed ID: 19048929
[TBL] [Abstract][Full Text] [Related]
14. High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients.
Yuan J; Wang H; Wu G; Liu H; Zhang Y; Yang L
Postgrad Med J; 2008 Jan; 84(987):46-9. PubMed ID: 18230751
[TBL] [Abstract][Full Text] [Related]
15. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
[TBL] [Abstract][Full Text] [Related]
16. [Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser].
Lipiński MI; Peszyński-Drews C; Jeromin MZ; Jeromin LM
Wiad Lek; 2006; 59(3-4):196-8. PubMed ID: 16813263
[TBL] [Abstract][Full Text] [Related]
17. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
18. Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true?
Araki M; Lam PN; Culkin DJ; Wong C
Urology; 2007 Nov; 70(5):927-30. PubMed ID: 18068449
[TBL] [Abstract][Full Text] [Related]
19. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
Matoka DJ; Averch TD
Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
[TBL] [Abstract][Full Text] [Related]
20. Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate.
Cho MC; Kim HS; Lee CJ; Ku JH; Kim SW; Paick JS
Urology; 2010 Jun; 75(6):1460-6. PubMed ID: 19963247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]